Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Anti-proliferative activity of A. Oxyphylla and its bioactive constituent nootkatone in colorectal cancer cells.

Authors:
Eunsu Yoo Jaehak Lee Pattawika Lertpatipanpong Junsun Ryu Chong-Tai Kim Eul-Yong Park Seung Joon Baek

BMC Cancer 2020 Sep 14;20(1):881. Epub 2020 Sep 14.

Department of Veterinary Medicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea.

Background: A. oxyphylla extract is known to possess a wide range of pharmacological activites. However, the molecular mechanism of A. oxyphylla and its bioactive compound nootkatone in colorectal cancer is unknown.

Methods: Our study aims to examine the role of A. oxyphylla and its bioactive compound nootkatone, in tumor suppression using several in vitro assays.

Results: Both A. oxyphylla extract and nootkatone exhibited antiproliferative activity in colorectal cancer cells. A. oxyphylla displayed antioxidant activity in colorectal cancer cells, likely mediated via induction of HO-1. Furthermore, expression of pro-apoptotic protein NAG-1 and cell proliferative protein cyclin D1 were increased and decreased respectively in the presence of A. oxyphylla. When examined for anticancer activity, nootkatone treatment resulted in the reduction of colony and spheroid formation. Correspondingly, nootkatone also led to increased NAG-1 expression and decreased cyclin D1 expression. The mechanism by which nootkatone suppresses cyclin D1 involves protein level regulation, whereas nootkatone increases NAG-1 expression at the transcriptional level. In addition to having PPARγ binding activity, nootkatone also increases EGR-1 expression which ultimately results in enhanced NAG-1 promoter activity.

Conclusion: In summary, our findings suggest that nootkatone is an anti-tumorigenic compound harboring antiproliferative and pro-apoptotic activity.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-020-07379-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491188PMC
September 2020

Publication Analysis

Top Keywords

colorectal cancer
16
cancer cells
12
oxyphylla bioactive
12
nootkatone
10
activity nootkatone
8
oxyphylla extract
8
nootkatone colorectal
8
nag-1 expression
8
bioactive compound
8
nootkatone increases
8
compound nootkatone
8
activity colorectal
8
oxyphylla
7
expression
5
activity
5
cell proliferative
4
proliferative protein
4
protein cyclin
4
cyclin increased
4
pparγ binding
4

Keyword Occurance

Similar Publications

Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival.

Authors:
Anders Jakobsen Rikke F Andersen Torben F Hansen Lars H Jensen Louise Faaborg Karina D Steffensen Caroline B Thomsen Sara W C Wen

Eur J Cancer 2021 Apr 12;149:128-133. Epub 2021 Apr 12.

Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Denmark; Department of Regional Health Research, University of Southern Denmark, Denmark.

Aim: The aim of the study was to compare ctDNA response rate and objective response rate as surrogate markers for overall survival (OS) in patients with metastatic cancer treated with chemotherapy.

Methods: The study included 420 patients distributed in five cohorts with colorectal, ovarian, and non-small cell lung cancer. It represents a retrospective analysis of patients enrolled in prospective biomarker studies and clinical trials. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

LncRNA signature in colorectal cancer.

Authors:
Soudeh Ghafouri-Fard Bashdar Mahmud Hussen Alireza Gharebaghi Reyhane Eghtedarian Mohammad Taheri

Pathol Res Pract 2021 Apr 7;222:153432. Epub 2021 Apr 7.

Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:

Colorectal cancer (CRC) is among the most frequent cancers and is associated with high mortality particularly when being diagnosed in advanced stages. Although several environmental and intrinsic risk factors have been identified, the underlying cause of CRC is not clear in the majority of cases. Several studies especially in the recent decade have pointed to the role of epigenetic factors in this kind of cancer. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trial.

Authors:
Danyal Ladha Ranjeeta Mallick Tzu-Fei Wang Lucia Caiano Philip S Wells Marc Carrier

Thromb Res 2021 Mar 21;202:151-154. Epub 2021 Mar 21.

Department of Medicine, Ottawa Hospital Research Institute at the University of Ottawa, Ontario, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. Electronic address:

Background: Recent trials have demonstrated that thromboprophylaxis using direct oral anticoagulants is effective but associated with a higher rate of major bleeding in intermediate-to-high risk (Khorana score ≥ 2) patients with cancer initiating systemic chemotherapy. Patients with gastrointestinal cancer may be at higher risk of major bleeding complications. We sought to assess the efficacy and safety of using thromboprophylaxis with apixaban in this patient population. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Participatory simulation modeling to inform colorectal cancer screening in a complex remote northern health system: Canada's Northwest Territories.

Authors:
Heather Anne Smith Jean Hai Ein Yong Kami Kandola Robin Boushey Craig Kuziemsky

Int J Med Inform 2021 Apr 8;150:104455. Epub 2021 Apr 8.

Office of Research Services, MacEwan University, Edmonton, AB, Canada.

Background & Aims: Colorectal cancer (CRC) mortality in the Northwest Territories (NWT), a northern region of Canada, could be reduced by implementing a CRC screening program. However, this may require additional colonoscopy resources. We used participatory simulation modeling to predict colonoscopy demand and to develop strategies for implementing a feasible and effective CRC screening program in this complex remote northern health system. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

TaTME approach as a rescue during a laparoscopic TME for high rectal cancer. A case report.

Authors:
F Carannante G Bianco S Lauricella G Mascianà M Caricato G T Capolupo

Int J Surg Case Rep 2021 Apr 7;82:105870. Epub 2021 Apr 7.

Colorectal Surgery Unit, Università Campus Bio-Medico, Via Alvaro del Portillo 21, 00128, Rome, Italy.

Introduction And Importance: In the last years, transanal total mesorectal excision (TaTME) has been described in rectal cancer treatment, especially in challenging patients, difficulties in pelvic exposure and limitations of instrumentation improving not only dissection but also the preservation of autonomic pelvic nerves and the achievement of a restorative procedure. Here we report a case report of anterior laparoscopic rectal resection for adenocarcinoma of the high-mid rectum converted to transanal approach.

Case Presentation: A 69-year-old male presented hepatic nodules during radiological follow-up for prostate cancer treated with radical prostatectomy and adjuvant radiotherapy (70 Gy). Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap